Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements (Q3068620): Difference between revisions
From MaRDI portal
Removed claims |
Set profile property. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / author | |||
| Property / author: Yuri Kogan / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Urszula Fory's / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Zvia Agur / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Latest revision as of 09:32, 5 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements |
scientific article |
Statements
Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements (English)
0 references
17 January 2011
0 references
glioblastoma
0 references
mathematical model
0 references
T cell
0 references
ordinary differential equation
0 references
local and global stability analysis
0 references
steady state
0 references
